Owens & Minor Q2 revenue up 4% to $2.7B; adjusted EPS doubles to $0.36; agrees to acquire Rotech

ACCENDRA HEALTH INC/VA/

2024-Q2 EPS reported -$0.70 revenue$5,283,686,000

Revenue $2.67B (+4% YoY); GAAP net loss $32M ($0.42 loss per share) vs. $28M loss last year.
Adjusted EBITDA $127M (+12% YoY); adjusted EPS $0.36 vs. $0.18, doubling year over year.
Operating cash flow $116M used to reduce debt by $71M during the quarter.
Agreement to acquire Rotech Healthcare Holdings to expand Patient Direct segment; expected close H2 2024.
Management reaffirms full-year 2024 adjusted EBITDA guidance of $515M-$545M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.